Overview
| Gender | Male |
|---|---|
| toru.ouchi@mssm.edu |
Toru Ouchi
ADJUNCT ASSOCIATE PROFESSOR Oncological Sciences
Research
Key Words: BRCA1, BRCA2, breast cancer, tumor suppressor
Molecular Basis for Breast Cancer Development:
Analysis of Tumor Suppressor Proteins
This laboratory is investigating the breast cancer susceptibility genes, BRCA 1 and BRCA 2. Recently, Dr. Ouchi and colleagues demonstrated that the BRCA 1 tumor suppressor acts in concert with STAT1 to differentially activate transcription of a subset of INF- gamma target genes and mediates growth inhibition by this cytokine. Other laboratory studies examine the function of BRCA 1 as a p53 coactivator and BRCA 2 as a physical and functional participant with p53 and RAD 51 in maintaining genome integrity.
Institutes, Centers, Programs and Laboratories
The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.
Clinical Trials
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.
